Clinical Microbiology Market

Clinical Microbiology Market by Application (Food, Pharma, Manufacturing, Chemical, Environment), Disease (Respiratory, Std, Uti), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnostic Lab, Academia) - Global Forecast to 2025

Report Code: MD 3092 Oct, 2020, by marketsandmarkets.com

[228 Pages Report] The global clinical microbiology market size is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.5% during the forecast period. The global microbiological testing/clinical microbiology market offers significant growth potential for prominent as well as emerging product manufacturers. Technological advancements, rising incidence of infectious diseases and growing outbreak of epidemics (such as COVID-19), and increased funding and public-private investments are some of the key factors driving the growth of the microbiological testing/clinical microbiology market.

Clinical Microbiology Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the global clinical microbiology market

The COVID-19 pandemic has significantly affected the clinical microbiology market. The market is facing challenges in the manufacturing and supply chain, such as delivering products to end-users in a timely manner as well as attending to an uneven demand for the products and services in the sector. In addition, a dearth of skilled lab professionals to conduct/study diagnostic tests, limited operations in most of the industries, inadequate funding for research and academic institutes, temporary closure of major academic institutes, disrupted supply chain, and challenges in providing essential/post-sales services due to lockdowns have led to the reduced supply of clinical microbiology products to end-users. Research institutes are one of the major end-users of clinical microbiology products. As the pandemic resulted in the temporary closure of several research institutes across the globe, this end-user segment has been affected drastically over the last few months.

Clinical Microbiology  Market Dynamics

Driver: Technological advancement in diseases diagnostics

Several emerging molecular diagnostic techniques are increasingly being used for early detection as well as the effective treatment of pathogen-borne diseases. Advanced molecular diagnostic techniques offer several technological benefits such as faster turnaround time, high sample throughput, multiplexing of reaction, specificity, better accuracy, and increased device sensitivity as compared to traditional laboratory techniques. Advanced molecular diagnostic techniques such as NGS, real-time PCR, molecular cartridges, and PCR coupled with mass spectrometry are increasingly being recognized for their capabilities in the identification and characterization of several pathogens as well as in the analysis of multiple samples in a single run. This has resulted in the increased preference as well as the growing adoption of these products among key end-users, including healthcare providers (such as hospitals and microbial and clinical centers), research laboratories, and pharmaceutical and biotechnology companies.

The development and commercialization of pathogen-specific reagent/diagnostic kits have led to better sample utilization as well as the adoption of a well-defined clinical methodology for specific disease diagnosis. In line with the changing end-user preferences, many prominent product manufacturers are focusing on developing and commercializing innovative and technologically advanced molecular diagnostic products for infectious disease diagnosis.

Restraint: Limited reimbursement policies for microbiology testing procedures

Clinical microbiology testing procedures are not adequately reimbursed across several countries such as India, China, and other emerging countries in the Middle East and Africa, which have a high target patient population base. This is a major factor that limits the preference for clinical microbiology products among patients and healthcare professionals. This directly affects the adoption of premium-priced clinical microbiology products, thereby negatively affecting their market growth. Laboratory tests performed for in-patients are reimbursed along with diagnosis-related group payment only, whereas reimbursements for out-patient laboratory tests are made locally. The lack of national standardization for reimbursements results in significant variation at the regional level. The adoption of microbial tests in the US is further restricted due to limited coverage for operational costs for these test procedures, restricted research use only (RUO) diagnostic products, and the slow inclusion of newly developed microbial test procedures in CPT codes for medical reimbursements.

Opportunity: Improving healthcare infrastructure across emerging countries

Emerging markets are expected to offer significant growth opportunities to clinical microbiology product manufacturers and distributors during the forecast period. This can be attributed to the growing prevalence of infectious diseases such as HIV, tuberculosis, influenza, and malaria as well as increasing R&D initiatives to develop innovative genomic techniques for efficient disease diagnosis in developing nations.

The growth in these markets is further supported by improvements in healthcare infrastructure, growing healthcare expenditure, and increasing availability and affordability of low-cost clinical microbiology products. In line with the ongoing trend, several government initiatives have been undertaken across emerging markets (particularly in China and India) to strengthen and expand the healthcare infrastructure.

Challenge: Operational barriers related to the use of diagnostic tests

Diagnostic microbiology tests involve various types of patient samples, such as semen, saliva, tissue, blood, and urine. These diagnostic tests have limited utilization of automated instruments to directly diagnose common pathogens such as Plasmodium, Staphylococcus, and E. coli. Clinical laboratories must have proper logistic support for timely sample collection, efficient transportation, and safe and standardized sample processing to provide correct and accurate diagnostic results to patients. However, meeting optimal criteria for sample handling and transportation is a key challenge faced by a majority of clinical laboratories. For instance, in the case of preanalytical sample processing, the sample should be procured at room temperature and transported at fixed temperatures only. Additionally, clinical laboratories must verify separate preanalytical and analytical procedures for individual matrix type so as to get optimal and correct results.

Clinical Microbiology Market

To know about the assumptions considered for the study, download the pdf brochure

By product, the instruments segment is expected to have the largest market share during the forecast period

The large share of this segment is attributed to factors such as the significant adoption of conventional laboratory instruments among researchers and academia (coupled with growing industry-academia collaborations for genomic research), technological advancements in the field of molecular techniques and proteomics (such as the integration of microfluidics with PCR and nanotechnology with qPCR techniques), and the ongoing trend of laboratory automation among clinical laboratories.

Pharmaceuticals is the largest application segment of the clinical microbiology/microbial testing market

The pharmaceutical applications segment is expected to dominate the overall microbial testing market during the forecast period. The large share of this segment is majorly attributed to the presence of well-established and globally accepted regulations that govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing. Several regulatory bodies [such as the WHO, FDA, Medicines and Healthcare Products Regulatory Agency (MHRA, UK), European Medicines Evaluation Agency (European Union), Therapeutic Goods Administration (TGA, Australia), and the Brazilian Health Regulatory Agency (ANVISA, Brazil)] have well-defined regulatory guidelines for the evaluation of microbial contamination in excipients and APIs to ensure sterile manufacturing of drugs and microbial load testing of finished pharmaceutical products. Additionally, pharmaceutical drug manufacturing processes are controlled and checked through various pharmacopeias globally. The growing volume of pharmaceutical drugs manufactured across the globe is another factor contributing to the growth of this application segment.

Hospital  & diagnostics centers accounted for the largest share of the clinical microbiology market, by end-users, in 2019

The growth of the clinical microbiology market for the hospitals and diagnostic centers segment is driven by the high incidence of target diseases (such as tuberculosis, HIV-AIDS, malaria, and epidemic diseases), availability of technologically advanced products (such as molecular diagnostic products, PCR and NGS-based instruments, and microscopy instruments) for infectious diseases diagnosis, growing awareness among doctors and clinicians regarding the advantages offered by molecular diagnostics products for fast and effective disease diagnosis, and ongoing expansion of healthcare infrastructure across emerging countries.

Clinical Microbiology Market by Region

North America is the largest regional market for Clinical Microbiology  

North America (comprising the US and Canada) dominates the clinical microbiology market. North America is a mature market, with high penetration of clinical microbiology technologies among key end-users (hospitals, diagnostic centers, research laboratories, and commercial service providers) and well-established distribution channels for clinical microbiology product manufacturers and suppliers. Easy accessibility to and the high adoption of advanced diagnostic technologies due to the significant per capita annual healthcare expenditure by the US and Canadian governments, as well as supportive government regulations, are driving the growth of the clinical microbiology market in this region.

Key Market Players

BioMιrieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), and Roche Diagnostics (Switzerland). Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).

Danaher is one of the leading companies in the clinical microbiology industry. The company operates in the clinical microbiology testing market through its wholly-owned subsidiaries Beckman Coulter and Cepheid. Danaher focuses on strengthening its position in the global microbiology/clinical testing market mainly by adopting the strategies of acquisitions and product launches. The company launched several innovative products, such as DxM 6100 Autoplak Advanced System, Xpert Xpress Flu Test Kit, DxONE Clinical Information Management Tools, Xpert Xpress Strep A Test Kit, Access 2 Immunoassay System, VERIS MDx System, VERIS Human CMV Assay, and UniCel DxH Connected Workcell Solution. These products have helped the company increase its revenue and maintain its position in the microbiology testing market.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2017–2025

Base Year Considered

2019

Forecast Period

2020–2025

Forecast Units

Value (USD Billion)

Segments Covered

Product, Application, Disease, End Users, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, the UK, France, Italy, Spain, and RoE), APAC (Japan, China, India, and the RoAPAC), LATAM (Brazil, Mexico, and RoLATAM), and MEA

Companies Covered

bioMιrieux (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Bruker Corporation (US), Hologic (US), Bio-Rad Laboratories (US), QIAGEN (Germany), Thermo Fisher Scientific (US), Agilent Technologies (US), Merck KGaA (US), Shimadzu Corporation (Japan), 3M (US), NEOGEN Corporation (US), Memmert (Germany), Hardy Diagnostics (US), Liofilchem (Italy), TCS Biosciences (UK), Vacutest Kima (Italy), Biotechnology Solutions (US), Rapid Micro Biosystems (US), New Horizons (US), Arrow Diagnostics (India), and OpGen (Germany)

This research report categorizes the clinical microbiology market based on type, application, mechanism, product, end user, and region.

By Product

  • Instruments
    • Laboratory Instruments
      • Incubators
      • Gram Stainers
      • Bacterial Colony Counters
      • Autoclave Sterilizers
      • Microbial Air Samplers
      • Anaerobic Culture Systems
      • Petri Dish Fillers
      • Blood Culture Systems
      • Other Laboratory Instruments
    • Microbial Analyzer
      • Molecular Diagnostics Instruments
      • Microscopes
      • Mass Spectrometers
  • Reagents
    • Pathogen-Specific Kits
    • General Reagents

By Application

  • Pharmaceuticals Applications
  • Food Testing Applications
  • Clinical Applications
  • Energy Applications
  • Chemical & Material Manufacturing Applications
  • Environmental Applications

By Disease

  • Respiratory Diseases
  • Bloodstream Infections
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases
  • Other Indications

By End Users

  • Hospitals & Diagnostics Centers
  • Custom Lab Service Providers
  • Academic & Research Institutes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa

Recent Developments

  • In 2019, bioMιrieux (France) acquired Invisible Sentinel (US), a company engaged in the development, manufacturing, and marking of molecular diagnostic tools for the rapid, accurate, and reliable detection of pathogens and spoilage organisms in food and beverages
  • In 2018, bioMιrieux (France) acquired Astute Medical (US), a manufacturer of immunoassays and protein biomarkers for high-risk medical conditions and disease identification and validation. This helped bioMιrieux to expand its portfolio of immunoassays.
  • In 2018, Beckman Coulter (US) and NTE-SENER (Spain) partnered to launch the DxM 6100 Autoplak Advanced System in Europe.
  • In 2017, Abbott (US) acquired Alere (US), a leading company in diagnostics and point-of-care testing. This acquisition helped the company expand its product portfolio and strengthen its market position in the clinical microbiology testing market.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 36)
  FIGURE 1 RESEARCH DESIGN
    2.1 SECONDARY DATA
           2.1.1 SECONDARY SOURCES
    2.2 PRIMARY DATA
        FIGURE 2 BREAKDOWN OF PRIMARIES: CLINICAL MICROBIOLOGY MARKET
    2.3 MARKET ESTIMATION METHODOLOGY
        FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
           2.3.1 REVENUE MAPPING-BASED MARKET ESTIMATION
           2.3.2 PROCEDURE-BASED MARKET ESTIMATION
                 FIGURE 4 MARKET SIZE ESTIMATION: CLINICAL MICROBIOLOGY MARKET
           2.3.3 PRIMARY RESEARCH VALIDATION
    2.4 DATA TRIANGULATION
        FIGURE 5 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS
    2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 45)
  FIGURE 6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
  FIGURE 7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION)
  FIGURE 8 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  FIGURE 9 CLINICAL MICROBIOLOGY MARKET SHARE, BY END USER, 2020 VS. 2025
  FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL MICROBIOLOGY MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW
        FIGURE 11 RISING INCIDENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE CLINICAL MICROBIOLOGY MARKET
    4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
        FIGURE 12 INSTRUMENTS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2025
    4.3 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER AND COUNTRY (2019)
        FIGURE 13 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC CLINICAL MICROBIOLOGY MARKET IN 2019
    4.4 GEOGRAPHIC ANALYSIS: CLINICAL MICROBIOLOGY MARKET, BY DISEASE (2019)
        FIGURE 14 RESPIRATORY DISEASES SEGMENT DOMINATES THE GLOBAL CLINICAL MICROBIOLOGY MARKET
    4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
        FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Technological advancements in disease diagnostics
                    5.2.1.2 Rising incidence of infectious diseases and growing outbreaks of epidemics
                    5.2.1.3 Increased funding and public-private investments
           5.2.2 RESTRAINTS
                    5.2.2.1 Limited reimbursement policies for microbiology testing procedures
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Improving healthcare infrastructure across emerging countries
           5.2.4 CHALLENGES
                    5.2.4.1 Operational barriers related to the use of diagnostic tests
                    5.2.4.2 Bundled sales of microbiology testing products - A key challenge for small and emerging reagent manufacturers
    5.3 IMPACT OF THE COVID-19 PANDEMIC ON THE CLINICAL MICROBIOLOGY MARKET
    5.4 REGULATORY SCENARIO
    5.5 ECOSYSTEM COVERAGE
    5.6 TECHNOLOGY ANALYSIS
    5.7 PRICING ANALYSIS
        TABLE 1 CLINICAL MICROBIOLOGY PRICING ANALYSIS, BY PRODUCT, 2019 (USD)

6 MICROBIOLOGY TESTING MARKET, BY APPLICATION (Page No. - 65)
    6.1 INTRODUCTION
        TABLE 2 MICROBIOLOGY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
    6.2 PHARMACEUTICAL
           6.2.1 GROWING VOLUME OF PHARMACEUTICAL DRUGS MANUFACTURED IS THE MAJOR FACTOR DRIVING MARKET GROWTH
                 TABLE  3 MICROBIOLOGY TESTING MARKET FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
    6.3 FOOD TESTING
           6.3.1 FOOD TESTING IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE MARKET
                 TABLE  4 MICROBIOLOGY TESTING MARKET FOR FOOD TESTING APPLICATIONS,  BY REGION, 2018–2025 (USD MILLION)
    6.4 CLINICAL
           6.4.1 GROWING PROCEDURAL VOLUME OF CLINICAL DIAGNOSTIC TESTS WILL PROPEL MARKET GROWTH
                 TABLE  5 MICROBIOLOGY TESTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
    6.5 ENERGY
           6.5.1 INCREASING CONSUMPTION & PRODUCTION OF BIOFUEL TO DRIVE MARKET GROWTH
                 TABLE  6 MICROBIOLOGY TESTING MARKET FOR ENERGY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
    6.6 CHEMICAL & MATERIAL MANUFACTURING
           6.6.1 CHEMICAL & MATERIAL MANUFACTURING APPLICATIONS TO WITNESS STEADY GROWTH DURING THE FORECAST PERIOD
                 TABLE  7 MICROBIOLOGY TESTING MARKET FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
    6.7 ENVIRONMENTAL
           6.7.1 RISING INCIDENCE OF AIR- & WATER-BORNE DISEASES TO SUPPORT MARKET GROWTH
                 TABLE  8 MICROBIOLOGY TESTING MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)

7 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT (Page No. - 73)
    7.1 INTRODUCTION
        TABLE 9 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
    7.2 INSTRUMENTS
        TABLE 10 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 11 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
        TABLE 12 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
        TABLE 13 CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           7.2.1 LABORATORY INSTRUMENTS
                 TABLE  14 LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE  15 LABORATORY INSTRUMENTS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
                 TABLE  16 LABORATORY INSTRUMENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
                 TABLE  17 LABORATORY INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.1 Incubators
                               7.2.1.1.1 Incubators will continue to dominate the clinical microbiology instruments market
                                         TABLE  18 INCUBATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.2 Gram stainers
                               7.2.1.2.1 Gram stainers are among the most widely used clinical microbiology instruments
                                         TABLE  19 GRAM STAINERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.3 Bacterial colony counters
                               7.2.1.3.1 Bacterial colony counters are used during diagnostic procedures
                                         TABLE  20 BACTERIAL COLONY COUNTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.4 Autoclave sterilizers
                               7.2.1.4.1 Autoclave sterilizers are used to eliminate the risk of microbial contamination
                                         TABLE  21 AUTOCLAVE STERILIZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.5 Microbial air samplers
                               7.2.1.5.1 Microbial air samplers are significant instruments used in diagnosing airborne diseases
                                         TABLE  22 MICROBIAL AIR SAMPLERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.6 Blood culture systems
                               7.2.1.6.1 Blood culture systems are used for end-to-end blood sample processing
                                         TABLE  23 BLOOD CULTURE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.7 Anaerobic culture systems
                               7.2.1.7.1 Anaerobic culture systems help to maintain an anaerobic environment
                                         TABLE  24 ANAEROBIC CULTURE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.8 Microbial culture systems
                               7.2.1.8.1 Microbial culture systems are automated systems for the culturing of samples
                                         TABLE  25 MICROBIAL CULTURE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.9 Petri dish fillers
                               7.2.1.9.1 Petri dish fillers are designed to work reliably in the absence of the operator
                                         TABLE  26 PETRI DISH FILLERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.1.10 Other laboratory instruments
                             TABLE 27 OTHER LABORATORY INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           7.2.2 MICROBIOLOGY ANALYZERS
                 TABLE  28 MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                 TABLE  29 MICROBIOLOGY ANALYZERS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
                 TABLE  30 MICROBIOLOGY ANALYZERS MARKET, BY END USER, 2018–2025 (USD MILLION)
                 TABLE  31 MICROBIOLOGY ANALYZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.2.1 Molecular diagnostic instruments
                               7.2.2.1.1 Molecular diagnostic instruments to register the highest growth in the forecast period
                                         TABLE 32 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.2.2 Microscopes
                               7.2.2.2.1 Microscopes are particularly helpful during the preliminary identification of pathogens
                                         TABLE 33 MICROSCOPES MARKET, BY REGION, 2018–2025 (USD MILLION)
                    7.2.2.3 Mass spectrometers
                               7.2.2.3.1 High accuracy of mass spectrometers to drive their adoption
                                         TABLE 34 MASS SPECTROMETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
    7.3 REAGENTS
        TABLE 35 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
        TABLE 36 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY DISEASE, 2018–2025 (USD MILLION)
        TABLE 37 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY END USER, 2018–2025 (USD MILLION)
        TABLE 38 CLINICAL MICROBIOLOGY REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)
           7.3.1 PATHOGEN-SPECIFIC KITS
                    7.3.1.1 Pathogen-specific kits provide efficient mechanical disruption of difficult-to-lyse microbes
                            TABLE 39 PATHOGEN-SPECIFIC KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
           7.3.2 GENERAL REAGENTS
                    7.3.2.1 General reagents offer significant data reproducibility
                            TABLE 40 GENERAL REAGENTS MARKET, BY REGION, 2018–2025 (USD MILLION)

8 CLINICAL MICROBIOLOGY MARKET, BY DISEASE (Page No. - 93)
    8.1 INTRODUCTION
        TABLE 41 CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
    8.2 RESPIRATORY DISEASES
           8.2.1 RESPIRATORY DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
                 TABLE  42 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD MILLION)
    8.3 BLOODSTREAM INFECTIONS
           8.3.1 BLOODSTREAM INFECTIONS CAN LEAD TO A REDUCED RISK OF ANTIBIOTIC RESISTANCE
                 TABLE  43 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2018–2025 (USD MILLION)
    8.4 GASTROINTESTINAL DISEASES
           8.4.1 GASTROINTESTINAL DISEASES HAVE A HIGHER PREVALENCE IN DEVELOPING COUNTRIES
                 TABLE  44 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2018–2025 (USD MILLION)
    8.5 SEXUALLY TRANSMITTED DISEASES
           8.5.1 RISING PREVALENCE OF STDS ACROSS MAJOR MARKETS TO PROPEL THE ADOPTION OF CLINICAL MICROBIOLOGY PRODUCTS
                 TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2018–2025 (USD MILLION)
    8.6 URINARY TRACT INFECTIONS
           8.6.1 GROWING NUMBER OF UTI CASES WILL DRIVE MARKET GROWTH
                 TABLE 46 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2018–2025 (USD MILLION)
    8.7 PERIODONTAL DISEASES
           8.7.1 EXPANDING PRODUCT PIPELINES OF MARKET PLAYERS TO SUPPORT MARKET GROWTH
                 TABLE 47 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2018–2025 (USD MILLION)
    8.8 OTHER DISEASES
        TABLE 48 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2018–2025 (USD MILLION)

9 CLINICAL MICROBIOLOGY MARKET, BY END USER (Page No. - 102)
    9.1 INTRODUCTION
        TABLE 49 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
    9.2 HOSPITALS & DIAGNOSTIC CENTERS
           9.2.1 HOSPITALS & DIAGNOSTIC CENTERS ARE THE LARGEST END USERS OF CLINICAL MICROBIOLOGY PRODUCTS
                 TABLE  50 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018–2025 (USD MILLION)
    9.3 CUSTOM LAB SERVICE PROVIDERS
           9.3.1 CUSTOM LAB SERVICE PROVIDERS ARE THE FASTEST-GROWING END USERS OF THE CLINICAL MICROBIOLOGY MARKET
                 TABLE  51 CLINICAL MICROBIOLOGY MARKET FOR CUSTOM LAB SERVICE PROVIDERS, BY REGION, 2018–2025 (USD MILLION)
    9.4 ACADEMIC & RESEARCH INSTITUTES
           9.4.1 HIGH PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH
                 TABLE 52 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)

10 CLINICAL MICROBIOLOGY MARKET, BY REGION (Page No. - 106)
     10.1 INTRODUCTION
          TABLE 53 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
     10.2 NORTH AMERICA
          FIGURE 17 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
          TABLE  54 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE  55 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE  56 NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  57 NORTH AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  58 NORTH AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  59 NORTH AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  60 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
          TABLE  61 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER,  2018–2025 (USD MILLION)
             10.2.1 US
                        10.2.1.1 The US is the largest market for clinical microbiology products
                                 TABLE  62 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  63 US: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  64 US: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  65 US: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  66 US: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Growing number of clinical diagnostic tests to drive market growth in Canada
                                 TABLE  67 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  68 CANADA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  69 CANADA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  70 CANADA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  71 CANADA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.3 EUROPE
          TABLE  72 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE  73 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE  74 EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  75 EUROPE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  76 EUROPE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  77 EUROPE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  78 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
          TABLE  79 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany is the largest and fastest-growing market for clinical microbiology products in Europe
                                 TABLE  80 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  81 GERMANY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  82 GERMANY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  83 GERMANY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  84 GERMANY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 High per capita healthcare expenditure in the country to support market growth
                                 TABLE  85 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  86 UK: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  87 UK: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  88 UK: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  89 UK: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing incidence of infectious diseases to drive market growth
                                 TABLE  90 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  91 FRANCE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  92 FRANCE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  93 FRANCE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  94 FRANCE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Increasing R&D investments by pharmaceutical companies will propel the demand for clinical microbiology products
                                 TABLE  95 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  96 ITALY: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET,  BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  97 ITALY: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  98 ITALY: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  99 ITALY: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Growth of Spain’s food and dairy industry will support market growth
                                 TABLE  100 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  101 SPAIN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  102 SPAIN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  103 SPAIN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  104 SPAIN: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.3.6 REST OF EUROPE
                    TABLE  105 ROE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE  106 ROE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  107 ROE: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  108 ROE: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  109 ROE: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.4 ASIA PACIFIC
          FIGURE 18 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT
          TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE 111 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
          TABLE 112 ASIA PACIFIC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 113 ASIA PACIFIC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 114 ASIA PACIFIC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 115 ASIA PACIFIC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
          TABLE 117 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan is the largest market for clinical microbiology in the APAC
                                 TABLE  118 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  119 JAPAN: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  120 JAPAN: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  121 JAPAN: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  122 JAPAN: CLINICAL MICROBIOLOGY REAGENTS MARKET,  BY TYPE, 2018–2025 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 China to register the highest growth during the forecast period
                                 TABLE  123 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  124 CHINA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  125 CHINA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  126 CHINA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  127 CHINA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 High incidence of infectious diseases in the country to drive the demand for clinical microbiology products
                                 TABLE  128 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  129 INDIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  130 INDIA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  131 INDIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  132 INDIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.4 SOUTH KOREA
                        10.4.4.1 Growing presence of key market players in the region to support market growth
                                 TABLE  133 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  134 SOUTH KOREA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  135 SOUTH KOREA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  136 SOUTH KOREA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  137 SOUTH KOREA: CLINICAL MICROBIOLOGY REAGENTS MARKET,  BY TYPE, 2018–2025 (USD MILLION)
             10.4.5 AUSTRALIA
                        10.4.5.1 Limitations with respect to research activities are expected to hamper the growth of the clinical microbiology market in Australia
                                 TABLE  138 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  139 AUSTRALIA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  140 AUSTRALIA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  141 AUSTRALIA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  142 AUSTRALIA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.4.6 REST OF APAC
                    TABLE  143 ROAPAC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE  144 ROAPAC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  145 ROAPAC: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  146 ROAPAC: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  147 ROAPAC: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.5 LATIN AMERICA
          TABLE  148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
          TABLE  149 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT,  2018–2025 (USD MILLION)
          TABLE  150 LATIN AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  151 LATIN AMERICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  152 LATIN AMERICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  153 LATIN AMERICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
          TABLE  154 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
          TABLE  155 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
             10.5.1 BRAZIL
                        10.5.1.1 Brazil is the largest market in Latin America for clinical microbiology products
                                 TABLE  156 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  157 BRAZIL: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  158 BRAZIL: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  159 BRAZIL: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  160 BRAZIL: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.5.2 MEXICO
                        10.5.2.1 Reluctance of healthcare professionals to adopt advanced diagnostic technologies to hamper the market growth
                                 TABLE  161 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                                 TABLE  162 MEXICO: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE,  2018–2025 (USD MILLION)
                                 TABLE  163 MEXICO: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  164 MEXICO: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                                 TABLE  165 MEXICO: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
             10.5.3 REST OF LATIN AMERICA
                    TABLE  166 ROLATAM: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE  167 ROLATAM: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  168 ROLATAM: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  169 ROLATAM: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  170 ROLATAM: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE WILL SUPPORT MARKET GROWTH
                    TABLE   171 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
                    TABLE  172 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  173 MIDDLE EAST & AFRICA: LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  174 MIDDLE EAST & AFRICA: MICROBIOLOGY ANALYZERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY REAGENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
                    TABLE  176 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE, 2018–2025 (USD MILLION)
                    TABLE  177 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 162)
     11.1 OVERVIEW
          FIGURE 19 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE CLINICAL MICROBIOLOGY MARKET, JANUARY 2017–AUGUST 2020
     11.2 MARKET SHARE ANALYSIS
          FIGURE 20 CLINICAL MICROBIOLOGY MARKET SHARE, BY KEY PLAYER, 2019
     11.3 COMPETITIVE SCENARIO
          FIGURE 21 PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
             11.3.1 KEY PRODUCT LAUNCHES & APPROVALS
             11.3.2 KEY PARTNERSHIPS & COLLABORATIONS
             11.3.3 KEY ACQUISITIONS
             11.3.4 KEY EXPANSIONS

12 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 166)
     12.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
             12.1.1 VENDOR INCLUSION CRITERIA
             12.1.2 STARS
             12.1.3 EMERGING LEADERS
             12.1.4 PERVASIVE
             12.1.5 PARTICIPANTS
                    FIGURE 22 CLINICAL MICROBIOLOGY MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019
     12.2 COMPANY PROFILES
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
             12.2.1 3M
                    FIGURE 23 3M: COMPANY SNAPSHOT (2019)
             12.2.2 ABBOTT LABORATORIES
                    FIGURE 24 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
             12.2.3 AGILENT TECHNOLOGIES
                    FIGURE 25 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
             12.2.4 BECTON, DICKINSON AND COMPANY
                    FIGURE 26 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
             12.2.5 BIOMΙRIEUX
                    FIGURE 27 BIOMΙRIEUX: COMPANY SNAPSHOT (2019)
             12.2.6 BIO-RAD LABORATORIES
                    FIGURE 28 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
             12.2.7 BRUKER CORPORATION
                    FIGURE 29 BRUKER CORPORATION: COMPANY SNAPSHOT (2019)
             12.2.8 DANAHER CORPORATION
                    FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
             12.2.9 HOLOGIC, INC.
                    FIGURE 31 HOLOGIC: COMPANY SNAPSHOT (2019)
             12.2.10 MERCK KGAA
                     FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2019)
             12.2.11 NEOGEN CORPORATION
                     FIGURE 33 NEOGEN CORPORATION: COMPANY SNAPSHOT (2019)
             12.2.12 QIAGEN
                     FIGURE 34 QIAGEN: COMPANY SNAPSHOT (2019)
             12.2.13 ROCHE DIAGNOSTICS
                     FIGURE 35 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
             12.2.14 SHIMADZU CORPORATION
                     FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2019)
             12.2.15 THERMO FISHER SCIENTIFIC
                     FIGURE 37 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
             12.2.16 EMERGING PLAYERS
                        12.2.16.1 Biotechnology Solutions
                        12.2.16.2 Hardy Diagnostics
                        12.2.16.3 Liofilchem
                        12.2.16.4 Rapid Micro Biosystems
                        12.2.16.5 TCS Biosciences
(Business Overview, Products Offered, Recent Developments, MnM View)*

13 APPENDIX (Page No. - 219)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

The study involved four major activities in estimating the current size of the clinical microbiology market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources, such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the orthopedic braces and supports the market study.

Primary Research

The clinical microbiology market comprises several stakeholders such as Clinical Microbiology Devices Manufacturing Companies, Healthcare service providers, manufacturers of pharmaceutical products, Clinical research organizations (CROs), Clinical testing laboratories, Food and beverages manufacturing companies, Manufacturers of petrochemical and biofuel products, Oil and gas production and distribution companies, Gas operators, distributors, and regulators, Environmental monitoring committees, Manufacturers of environmental monitoring products, National and regional pollution control boards and organizations, research laboratories and academic institutes and Market research and consulting firms. The demand side of this market is characterized by the increasing incidence of the rising incidence of infectious diseases and the growing outbreak of epidemics (such as COVID-19), and increased funding and public-private investments. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:

Clinical Microbiology Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the clinical microbiology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the clinical microbiology market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the clinical microbiology industry.

Report Objectives

  • To define, describe, and forecast the global microbiology testing market based on application
  • To define, describe, and forecast the global clinical microbiology market based on product, disease, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, growth opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders
  • To forecast the size of the market segments with respect to five main regions—North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East and Africa
  • To profile the key market players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as mergers and acquisitions, new product developments, partnerships, agreements, collaborations, and expansions in the global clinical microbiology market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the clinical microbiology market report:

Product Analysis

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top five global players

Product Analysis

  • Further breakdown of the Rest of Europe clinical microbiology market into Poland, Italy, Spain, and other European countries (aggregated)

Company Information

  • Detailed analysis and profiling of additional market players (up to 5 OEMs)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Clinical Microbiology Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Clinical Microbiology Market

Request For Special Pricing
Report Code
MD 3092
Published ON
Oct, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Clinical Microbiology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home